The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| OBSV | +0% | -100% | -86.45% | -100% |
| S&P | +15.06% | +95.03% | +14.29% | +193% |
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.
Currently no data to display
Currently no data to display.
Currently no data to display.
| Metric | YoY Change |
|---|
OBSV earnings call for the period ending December 31, 2019.
OBSV earnings call for the period ending September 30, 2019.
OBSV earnings call for the period ending March 31, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
